Klein F A, Smith M J, Greenfield L J
J Urol. 1984 May;131(5):880-3. doi: 10.1016/s0022-5347(17)50692-8.
Extension of tumor into the vena cava occurs in 5 to 10 per cent of the cases of renal cell carcinomas. Of these cases 14 to 39 per cent may extend to or into the right atrium. Acceptable techniques for dealing with this situation include cross-clamping the atrium, using positive pressure ventilation and extracting the thrombus with a Fogarty or Foley catheter, and extracorporeal circulation or a cardiopulmonary bypass with open excision of the tumor extension. Since 1974 we have seen 2 men and 2 women, mean age 56 years, with clear cell renal carcinomas and supradiaphragmatic vena caval tumor extension (1 with additional pulmonary embolism). None had other evidence of metastatic disease determined on staging evaluation by celiac and renal angiography, liver scan, bone scan and chest tomography. Each patient was explored with the planned use of extracorporeal circulation or cardiopulmonary bypass, Greenfield vena caval filter insertion and standard radical nephrectomy. Resection was not done in 1 patient with biopsy proved tumor eroding through the right atrial wall. He died of disease in 8 months. Of the remaining 3 patients who had the tumors completely resected 1 is alive with recurrent disease in the retroperitoneum at 44 months, 1 died of metastatic disease to the bones and liver at 39 months, and 1 died 1 day postoperatively of technical complications with no evidence of residual disease at autopsy. In the absence of metastatic disease it seems reasonable to pursue a radical surgical approach in patients with renal cell carcinoma and supradiaphragmatic tumor thrombus. The use of extracorporeal circulation and post-extraction insertion of the Greenfield vena caval filter offers the surgeon the advantage of direct visualization and better vascular control in removing the thrombus, as well as protection from the possibility of post-extraction pulmonary embolism. With the combined use of these techniques, the previously hopeless situation for these patients has been improved.
肿瘤侵犯至腔静脉的情况在肾细胞癌病例中占5%至10%。在这些病例中,14%至39%可能会延伸至右心房或侵犯右心房。处理这种情况的可接受技术包括钳夹心房、使用正压通气并用Fogarty或Foley导管取出血栓,以及体外循环或心肺转流并开放切除肿瘤延伸部分。自1974年以来,我们共诊治了2名男性和2名女性患者,平均年龄56岁,均为透明细胞肾细胞癌且肿瘤延伸至膈上腔静脉(1例伴有额外的肺栓塞)。通过腹腔动脉造影、肾动脉造影、肝脏扫描、骨扫描和胸部断层扫描进行分期评估,均未发现其他转移疾病的证据。每位患者均计划在体外循环或心肺转流、置入Greenfield腔静脉滤器及标准根治性肾切除术的情况下进行探查。1例经活检证实肿瘤侵蚀右心房壁的患者未进行切除手术。他在8个月后死于疾病。其余3例肿瘤完全切除的患者中,1例在44个月时出现腹膜后复发性疾病仍存活,1例在39个月时死于骨和肝转移,1例术后1天死于技术并发症,尸检未发现残留疾病迹象。在无转移疾病的情况下,对于肾细胞癌合并膈上肿瘤血栓的患者,采取根治性手术方法似乎是合理的。使用体外循环及取出血栓后置入Greenfield腔静脉滤器,为外科医生在清除血栓时提供了直接可视化和更好的血管控制优势,同时也可防止取出血栓后发生肺栓塞。通过这些技术的联合应用,这些患者以前绝望的情况得到了改善。